Search

everythinglearnresearchcommunity

for

Search:↓

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Many women in Turkey have hirsutism, according to the research group's findings.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

The document lists various dermatology topics, treatments, and diagnostic methods.

New treatments for alopecia areata show promise, but standardized guidelines are needed.